E. O. ROS, “The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited”, React Oxyg Species (Apex), vol. 11, pp. n7–n8, Feb. 2021.